Fig. 2From: De-escalating chemotherapy for stage I–II gastric neuroendocrine carcinoma? A real-world competing risk analysisKM analyses of stage I-II GNEC patients. OS (A) and CSS (B) curves before PSM. OS (C) and CSS (D) curves after PSMBack to article page